W.R. Berkley Corp’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-106,026
Closed -$951K 108
2016
Q3
$951K Buy
+106,026
New +$754K 0.1% 58

W.R. Berkley Corp's RPTP Position: Q4 2016 in Review

W.R. Berkley Corp sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 106,026 shares — an estimated $951K sold.

W.R. Berkley Corp first reported a position in RPTP in Q3 2016 and held it in 1 quarter. The position peaked at $951K in Q3 2016. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.

  • W.R. Berkley Corp reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
  • W.R. Berkley Corp sold 106,026 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $951K.
  • W.R. Berkley Corp first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q3 2016 and held it in 1 quarter.
  • W.R. Berkley Corp's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $951K in Q3 2016.
  • 0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.

Based on W.R. Berkley Corp's 13F filing for Q4 2016, filed 14 Feb 2017.